What Trump’s win means for cannabis (Newsletter: November 7, 2024)

KY voters approve medical cannabis; DOJ funds hemp & marijuana research; Study: cannabis for opiate harm reduction

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

(function() {
window.mc4wp = window.mc4wp || {
listeners: [],
forms: {
on: function(evt, cb) {
window.mc4wp.listeners.push(
{
event : evt,
callback: cb
}
);
}
}
}
})();

Your support makes Marijuana Moment possible…

Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.

Support our work at https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

Donald Trump’s election as president could have vast implications for marijuana reform. He has voiced support for cannabis industry access to the banking system and the federal rescheduling process initiated by the Biden administration, but questions remain about whether he will follow through or be able to get Republican members of Congress on board with the reforms.

Kentucky voters in 106 municipalities and counties decided on local ballot measures to allow medical cannabis businesses to operate on Tuesday—and every single one was approved.

The Department of Justice’s National Institute of Justice has awarded two grants to fund research into hemp, marijuana and processes to differentiate the two forms of the cannabis plant from one another.

A new scientific review concludes that “cannabis has a great deal of potential for opiate related harm reduction and substitute therapies” and that marijuana “has a better side effect profile and less severe long-term health effects than opiates.”

“The proven efficacy of cannabis in pain management and cancer, coupled with its other uses/benefits and rather safe side effect profile make it an excellent candidate for further exploration in substitute addiction research.”

/ FEDERAL

Rep. Seth Moulton (D-MA) posted a video ahead of the election urging Massachusetts voters to approve a psychedelics legalization initiative that ultimately failed.

/ STATES

South Dakota Gov. Kristi Noem (R) tweeted, “I’ve never met anyone who got smarter by smoking dope. South Dakotans agreed with me (again) tonight and voted down radical marijuana policy.”

California voters approved a ballot measure to increase penalties for certain drug and other crimes.

Oregon regulators published a bulletin on renewal of marijuana licenses with pending change requests.

Massachusetts regulators will hold a public listening session on cannabis testing laboratory issues on Thursday.

The Mississippi Cannabis Legislative Advisory Board will meet on Thursday.

The New York Cannabis Control Board will meet on Tuesday.

—
Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—

/ LOCAL

Voters in several Michigan municipalities decided on ballot questions on whether to allow marijuana businesses to operate.

Colorado Springs, Colorado voters appeared to approve competing ballot measures on whether to allow recreational marijuana sales.

Oakland, California’s Cannabis Regulatory Commission will meet on Thursday.

/ INTERNATIONAL

The Philippine justice secretary created a task force to investigate killings in the nation’s bloody “war on drugs.”

/ SCIENCE & HEALTH

A review concluded that “there is sufficient clinical and preclinical evidence of CBD in pain treatment, so CBD could be an effective and safe treatment in reducing pain due to its analgesic and anti-inflammatory properties.”

A review substantiates “the claim that psilocybin is superior in treating depression compared to established psychotherapy alone used for treating depression.”

/ BUSINESS

SNDL Inc. closed its acquisition of the Indiva Group’s business and assets, and also reported quarterly net revenue of C$236.9 million and an operating loss of C$18.5 million.

Curaleaf Holdings, Inc. reported quarterly net revenue of $330.5 million and a net loss of $42.7 million. It separately completed a new $40 million revolving credit facility.

Aurora Cannabis Inc. reported quarterly net revenue of C$81.1 million.

Curaleaf is being sued by a former executive over alleged pay bias and sexual harassment.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

(function() {
window.mc4wp = window.mc4wp || {
listeners: [],
forms: {
on: function(evt, cb) {
window.mc4wp.listeners.push(
{
event : evt,
callback: cb
}
);
}
}
}
})();